Jean Jacques Bienaime Keros Therapeutics, Inc. (KROS) insider trading activity

Jean Jacques Bienaime is of Keros Therapeutics, Inc.. Currently has a direct ownership of 5,450 shares of KROS, which is worth approximately $74,828. The most recent transaction as insider was on Jun 04, 2025, when has been sold 5,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.45K

n/a 3M change

n/a 12M change

Total Value Held $74,828

JEAN JACQUES BIENAIME Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 04 2025	BUY Grant, award, or other acquisition	-	5,250 Added 49.07%	5,450 Common Stock

Also insider at

INCY

INCYTE CORP Healthcare

Director

BMRN

BIOMARIN PHARMACEUTICAL INC Healthcare

Director

IMNM

Immunome Inc. Healthcare

JJB